Marsha A. McLaughlin

1.1k total citations
31 papers, 833 citations indexed

About

Marsha A. McLaughlin is a scholar working on Ophthalmology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Marsha A. McLaughlin has authored 31 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Ophthalmology, 11 papers in Molecular Biology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Marsha A. McLaughlin's work include Glaucoma and retinal disorders (26 papers), Ocular Surface and Contact Lens (8 papers) and Nitric Oxide and Endothelin Effects (5 papers). Marsha A. McLaughlin is often cited by papers focused on Glaucoma and retinal disorders (26 papers), Ocular Surface and Contact Lens (8 papers) and Nitric Oxide and Endothelin Effects (5 papers). Marsha A. McLaughlin collaborates with scholars based in United States, China and Switzerland. Marsha A. McLaughlin's co-authors include Najam A. Sharif, Mark R. Hellberg, Jesse A. May, Louis DeSantis, Paul W. Zinke, Curtis R. Kelly, Carol B. Toris, G. Zhan, George C.Y. Chiou and Naj Sharif and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

Marsha A. McLaughlin

31 papers receiving 800 citations

Peers

Marsha A. McLaughlin
Larry P. Bausher United States
Yvonne Davies United Kingdom
Nikolay Pozdnyakov United States
N. Virmaux France
S.-C.J. Fu United States
Sheryl J. Hays United States
D. C. Anderson United States
Larry P. Bausher United States
Marsha A. McLaughlin
Citations per year, relative to Marsha A. McLaughlin Marsha A. McLaughlin (= 1×) peers Larry P. Bausher

Countries citing papers authored by Marsha A. McLaughlin

Since Specialization
Citations

This map shows the geographic impact of Marsha A. McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marsha A. McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marsha A. McLaughlin more than expected).

Fields of papers citing papers by Marsha A. McLaughlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marsha A. McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marsha A. McLaughlin. The network helps show where Marsha A. McLaughlin may publish in the future.

Co-authorship network of co-authors of Marsha A. McLaughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Marsha A. McLaughlin. A scholar is included among the top collaborators of Marsha A. McLaughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marsha A. McLaughlin. Marsha A. McLaughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toris, Carol B., Marsha A. McLaughlin, Shan Fan, et al.. (2016). Effects of Rho Kinase Inhibitors on Intraocular Pressure and Aqueous Humor Dynamics in Nonhuman Primates and Rabbits. Journal of Ocular Pharmacology and Therapeutics. 32(6). 355–364. 19 indexed citations
2.
Ward, Jennifer, Curtis R. Kelly, Marsha A. McLaughlin, et al.. (2014). In vivo optimization of 2,3-diaminopyrazine Rho Kinase inhibitors for the treatment of glaucoma. Bioorganic & Medicinal Chemistry Letters. 24(8). 1875–1879. 14 indexed citations
3.
MacKay, Edward O., et al.. (2011). Dose response for travoprost®in the glaucomatous beagle. Veterinary Ophthalmology. 15(s1). 31–35. 5 indexed citations
4.
Davis, Robert L., Mehmet Kahraman, Thomas J. Prins, et al.. (2010). Benzothiophene containing Rho kinase inhibitors: Efficacy in an animal model of glaucoma. Bioorganic & Medicinal Chemistry Letters. 20(11). 3361–3366. 21 indexed citations
5.
Toris, Carol B., et al.. (2010). Aqueous humor dynamics in inbred rhesus monkeys with naturally occurring ocular hypertension. Experimental Eye Research. 91(6). 860–865. 6 indexed citations
6.
Sharif, Najam A., Marsha A. McLaughlin, Curtis R. Kelly, et al.. (2008). Cabergoline: Pharmacology, ocular hypotensive studies in multiple species, and aqueous humor dynamic modulation in the Cynomolgus monkey eyes. Experimental Eye Research. 88(3). 386–397. 30 indexed citations
7.
Hellberg, Mark R., et al.. (2008). Discovery of 13-oxa prostaglandin analogs as antiglaucoma agents: Synthesis and biological activity. Bioorganic & Medicinal Chemistry. 17(2). 576–584. 9 indexed citations
8.
Sharif, Najam A., Marsha A. McLaughlin, & Curtis R. Kelly. (2007). AL-34662: A Potent, Selective, And Efficacious Ocular Hypotensive Serotonin-2 Receptor Agonist. Journal of Ocular Pharmacology and Therapeutics. 23(1). 1–13. 20 indexed citations
9.
Mohapatra, Suchismita, Peter G. Klimko, Mark R. Hellberg, et al.. (2007). Novel benzodifuran analogs as potent 5-HT2A receptor agonists with ocular hypotensive activity. Bioorganic & Medicinal Chemistry Letters. 17(11). 2998–3002. 28 indexed citations
10.
Toris, Carol B., et al.. (2006). Effects of a Prostaglandin DP Receptor Agonist, AL-6598, on Aqueous Humor Dynamics in a Nonhuman Primate Model of Glaucoma. Journal of Ocular Pharmacology and Therapeutics. 22(2). 86–92. 15 indexed citations
11.
Sharif, Najam A., Marsha A. McLaughlin, Curtis R. Kelly, et al.. (2006). Preclinical Pharmacology of AL-12182, a New Ocular Hypotensive 11-Oxa Prostaglandin Analog. Journal of Ocular Pharmacology and Therapeutics. 22(5). 291–309. 14 indexed citations
12.
Sharif, Najam A., Curtis R. Kelly, & Marsha A. McLaughlin. (2006). Human Trabecular Meshwork Cells Express Functional Serotonin-2A (5HT2A) Receptors: Role in IOP Reduction. Investigative Ophthalmology & Visual Science. 47(9). 4001–4001. 20 indexed citations
13.
Klimko, Peter G., Mark R. Hellberg, Marsha A. McLaughlin, et al.. (2004). 15-Fluoro prostaglandin FP agonists: a new class of topical ocular hypotensives. Bioorganic & Medicinal Chemistry. 12(13). 3451–3469. 18 indexed citations
14.
Hellberg, Mark R., Najam A. Sharif, Marsha A. McLaughlin, et al.. (2004). AL-12182, a novel 11-oxa prostaglandin analog with topical ocular hypotensive activity in the monkey. Bioorganic & Medicinal Chemistry Letters. 14(17). 4525–4528. 7 indexed citations
15.
Glennon, Richard A., Nantaka Khorana, Richard Young, et al.. (2004). β-Oxygenated Analogues of the 5-HT2ASerotonin Receptor Agonist 1-(4-Bromo-2,5-dimethoxyphenyl)-2-aminopropane. Journal of Medicinal Chemistry. 47(24). 6034–6041. 16 indexed citations
16.
Toris, Carol B., G. Zhan, & Marsha A. McLaughlin. (2003). Effects of Brinzolamide on Aqueous Humor Dynamics in Monkeys and Rabbits. Journal of Ocular Pharmacology and Therapeutics. 19(5). 397–404. 20 indexed citations
17.
Fingert, John H., A.F. Clark, Jamie E. Craig, et al.. (2001). Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension.. PubMed. 42(1). 145–52. 98 indexed citations
18.
Hellberg, Mark R., Verney L. Sallee, Marsha A. McLaughlin, et al.. (2001). Preclinical Efficacy of Travoprost, a Potent and Selective FP Prostaglandin Receptor Agonist. Journal of Ocular Pharmacology and Therapeutics. 17(5). 421–432. 96 indexed citations
19.
Pang, Iok-Hou, et al.. (2001). Ocular Hypotensive and Aqueous Outflow-enhancing Effects of AL-3037A (Sodium Ferri Ethylenediaminetetraacetate). Experimental Eye Research. 73(6). 815–825. 15 indexed citations
20.
Chiou, George C.Y., et al.. (1985). Are β-Adrenergic Mechanisms Involved in Ocular Hypotensive Actions of Adrenergic Drugs?. Ophthalmic Research. 17(1). 49–53. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026